Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,501 to 1,520 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developments of CRBN-based PROTACs as potential therapeutic agents. | Eur J Med Chem | 2021 | 34411892 | PubTator, text mining | PubMed |
| Targeted Degradation of the Oncogenic Phosphatase SHP2. | Biochemistry | 2021 | 34411482 | PubTator, text mining | PubMed |
| Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG. | Adv Sci (Weinh) | 2021 | 34397171 | PubTator, text mining | PubMed |
| BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity. | EMBO Rep | 2021 | 34397140 | PubTator, text mining | PubMed |
| Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery. | Front Chem | 2021 | 34395393 | PubTator, text mining | PubMed |
| Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation. | Eur J Immunol | 2021 | 34392531 | PubTator, text mining | PubMed |
| RNA-binding protein 39: a promising therapeutic target for cancer. | Cell Death Discov | 2021 | 34389703 | PubTator, text mining | PubMed |
| Folate-Guided Protein Degradation by Immunomodulatory Imide Drug-Based Molecular Glues and Proteolysis Targeting Chimeras. | J Med Chem | 2021 | 34378936 | PubTator, text mining | PubMed |
| Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. | Leukemia | 2021 | 34373585 | PubTator, text mining | PubMed |
| From the Farm to the Lab: How Chicken Embryos Contribute to the Field of Teratology. | Front Genet | 2021 | 34367238 | PubTator, text mining | PubMed |
| Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment. | Bioorg Med Chem | 2021 | 34364224 | PubTator, text mining | PubMed |
| Genome-wide association study of trypanosome prevalence and morphometric traits in purebred and crossbred Baoulé cattle of Burkina Faso. | PLoS One | 2021 | 34351956 | PubTator, text mining | PubMed |
| Light-Controllable PROTACs for Temporospatial Control of Protein Degradation. | Front Cell Dev Biol | 2021 | 34350175 | PubTator, text mining | PubMed |
| Alternative splicing of BCL-X and implications for treating hematological malignancies. | Oncol Lett | 2021 | 34345295 | PubTator, text mining | PubMed |
| Cytomegalovirus late transcription factor target sequence diversity orchestrates viral early to late transcription. | PLoS Pathog | 2021 | 34339482 | PubTator, text mining | PubMed |
| Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients. | Front Oncol | 2021 | 34336672 | PubTator, text mining | PubMed |
| TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma. | Cancer Cell | 2021 | 34329586 | PubTator, text mining | PubMed |
| Developing next generation immunomodulatory drugs and their combinations in multiple myeloma. | Oncotarget | 2021 | 34316334 | PubTator, text mining | PubMed |
| Chemo-proteomics exploration of HDAC degradability by small molecule degraders. | Cell Chem Biol | 2021 | 34314730 | PubTator, text mining | PubMed |
| Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma. | Cancer Sci | 2021 | 34310776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=76